TIM-3 is a co-inhibitory molecule often expressed by CD8+ T cells or dendritic cells in the tumor microenvironment (de Mingo Pulido et al., 2021; Dixon et al., 2021; Wolf et al., 2020). The gene discussed is HAVCR2; the disease is neoplasm.